An extension of cancer immunotherapy with dostarlimab, the PD1-PD L1 pathway blocker
Cancer immunotherapy is a treatment that uses the body's own immune system to fight against cancer. Malignant cells in the human body have the ability to mutate themselves in such a way that they can escape from immune system surveillance and proliferate. So, if the human immune system could be...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402310377X |